UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 30, 2026
Accession Number:
0001214659-26-003935
Submission Type:
POS AM
CIK:
0001643918
Company Name:
Biodexa Pharmaceuticals Plc
File Number:
333-284350